Smoking, von Willebrand factor and ADAMTS-13 in healthy males

被引:10
作者
Al-Awadhi, Anwar M. [1 ]
Jadaon, Mehrez M. [1 ]
Alsayegh, Faisal A. [2 ]
Al-Sharrah, Seham K. [1 ]
机构
[1] Kuwait Univ, Fac Allied Hlth Sci, Dept Med Lab Sci, Sulibikhat 90805, Kuwait
[2] Kuwait Univ, Fac Med, Dept Med, Sulibikhat 90805, Kuwait
关键词
ADAMTS-13; protein; cleaving protease; ELISA; smoking; von Willebrand factor; THROMBOTIC THROMBOCYTOPENIC PURPURA; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CLEAVING PROTEASE; CIGARETTE-SMOKING; ATHEROSCLEROSIS; DIAGNOSIS; PLASMA; ENDOTHELIUM; DISORDERS;
D O I
10.3109/00365513.2012.725864
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
While von Willebrand factor (vWF) has been reported to be elevated in smokers, there are no reports on the effects of smoking on its cleaving protease ADAMTS-13, particularly in subjects of Arab ethnicity. This study was conducted to determine the effects of smoking on vWF and ADAMTS-13 antigen and activity levels in Arab males. Venous blood samples from 80 smoking (at rest) and 80 non-smoking healthy males were collected after asking subjects to fast and refrain from smoking for 8 hours. Similar sampling was done for 40 smokers (acute smokers), who were asked to smoke one cigarette immediately before blood collection. Plasma was used to measure ADAMTS-13 antigen and activity levels, as well as vWF antigen and collagen binding activity levels using commercial ELISA kits. Compared to non-smokers, ADAMTS-13 and vWF activities were significantly lower in smokers at rest (p < 0.05). Acute smokers had significantly higher levels of vWF activity and ADAMTS-13 antigen and activity levels (p < 0.01), compared to smokers at rest. Our results suggest that high vWF activity is accompanied by an increase in ADAMTS-13 activity as a natural physiological mechanism to degrade the elevated vWF molecules. If not followed by a subsequent smoke, the activities of both proteins subside. It is possible that the repeated increase in vWF and constant degradation by ADAMTS-13 results in lower overall levels of both proteins in smokers (at rest) compared to nonsmokers who do not experience a similar (repeated) injury to the endothelium.
引用
收藏
页码:614 / 618
页数:5
相关论文
共 25 条
  • [1] ADAMTS-13 Antigen and Activity Levels in Thrombocytopenic Disorders Including Thrombotic Thrombocytopenic Purpura in Kuwait
    Al-Awadhi, A. M.
    Jadaon, M. M.
    Al-Jafar, H. A.
    Al-Wazzan, H. J.
    [J]. ACTA HAEMATOLOGICA, 2011, 125 (03) : 160 - 166
  • [2] NICOTINE ALTERS FIBRONECTIN AND FACTOR-VIII/VWF IN HUMAN VASCULAR ENDOTHELIAL-CELLS
    BLAES, N
    PIOVELLA, F
    SAMADEN, A
    BOUTHERINFALSON, O
    RICETTI, M
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 675 - 687
  • [3] VON-WILLEBRAND-FACTOR, ENDOTHELIAL-CELL DAMAGE AND ATHEROSCLEROSIS
    BLANN, AD
    MCCOLLUM, CN
    [J]. EUROPEAN JOURNAL OF VASCULAR SURGERY, 1994, 8 (01): : 10 - 15
  • [4] The influence of acute smoking on leucocytes, platelets and the endothelium
    Blann, AD
    Kirkpatrick, U
    Devine, C
    Naser, S
    McCollum, CN
    [J]. ATHEROSCLEROSIS, 1998, 141 (01) : 133 - 139
  • [5] Young male smokers have altered platelets and endothelium that precedes atherosclerosis
    Casey, RG
    Joyce, M
    Roche-Nagle, G
    Cox, D
    Bouchier-Hayes, DJ
    [J]. JOURNAL OF SURGICAL RESEARCH, 2004, 116 (02) : 227 - 233
  • [6] FAVALORO EJ, 1995, AM J CLIN PATHOL, V104, P264
  • [7] Laboratory assays for von Willebrand factor: Relative contribution to the diagnosis of von Willebrand's disease
    Favaloro, EJ
    Koutts, J
    [J]. PATHOLOGY, 1997, 29 (04) : 385 - 391
  • [8] Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
    Furlan, M
    Robles, R
    Lammle, B
    [J]. BLOOD, 1996, 87 (10) : 4223 - 4234
  • [9] ETHNIC VARIATIONS IN THE HEMOSTATIC SYSTEM - COMPARISON BETWEEN ARABS, WESTERNERS (EUROPEANS AND AMERICANS), ASIANS AND AFRICANS
    GADER, A
    BAHAKIM, H
    AWADALLA, S
    MALAIKA, S
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) : 537 - 542
  • [10] JANSSON JH, 1991, BRIT HEART J, V66, P351